摘要
目的分析倍他司汀联合复方丹参注射液治疗椎基底动脉供血不足的临床疗效。方法将2013年6月至2016年6月100例椎基底动脉供血不足患者平均分为对照组与实验组,对照组给予复方丹参注射液治疗,实验组采用倍他司汀联合复方丹参注射液用药方案。比较两组临床疗效。结果治疗后实验组患者的左、右椎动脉、基底动脉Vm指数改善明显较对照组更优(P<0.05);实验组治疗总有效率为98.0%,明显高于对照组的82.0%,差异具有统计学意义(P<0.05)。结论倍他司汀联合复方丹参注射液治疗椎基底动脉供血不足效果确切,可有效改善椎基底动脉系统血液供给,值得推广和应用。
Objective To analyze the clinical effect of treating vertebral basilar artery insufficiency with betahistine and compound Danshen injection.Methods From June 2013 to June 2016, 100 cases of patients with vertebral basilar artery insufficiency were divided into control group and experimental group. The control group was treated with Compound Danshen injection. The experimental group was treated with the combination of the combination of betahistine and compound Danshen injection. The clinical efficacy of the two groups was compared. Results After the treatment, Vm index improvement of the left and right vertebral artery and basilar artery of the patients in the experimental group was significantly better than the control group （P〈0.05）. The total effective rate of experimental group was 98%, which was significantly higher than 82% of the control group, there was statistical significant （P 〈 0. 05 ）. Conclusions Betahistine and compound Danshen injection can effectively improve the blood supply of vertebral basilar artery system, and it is worth popularizing and applying.
出处
《齐齐哈尔医学院学报》
2016年第35期4382-4383,共2页
Journal of Qiqihar Medical University
关键词
椎基底动脉供血不足
动脉粥样硬化
倍他司汀
复方丹参注射液
Insufficient blood supply of vertebral basilar artery
Atherosclerosis
Betahistine
Compound Danshen Injection
